Parting ways with Agoracom? MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that the Company has agreed to settle an amount of $65,000 owing to a professional advisor, subject to all relevant consents and approvals, by issuing 500,000 common shares to the vendor, at a price of $0.13 per share. Regulatory and other consents will include acceptance from the TSX Venture Exchange.
Agoracom should refuse the payout offer from MDX and issue an apology for the minimal, ineffective marketing service they have provided.